SOLANO (Completed)
A Randomized, Parallel, Double-Blind, Placebo-Controlled Phase 2b Study to Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants with Hyperlipidaemia
- Medicine
- AZD8233 (subcutaan PCSK9-i)
- Population
- ASCVD
- Phase
- II
- Starting year
- 2020